Literature DB >> 12397190

Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.

Waqar Shamim1, Mohammed Yousufuddin, Duolao Wang, Michael Henein, Hubert Seggewiss, Marcus Flather, Andrew J S Coats, Ulrich Sigwart.   

Abstract

BACKGROUND: In patients with hypertrophic cardiomyopathy and obstruction of the left ventricular outflow tract, nonsurgical reduction of the septum is a treatment option when medical therapy has failed. We investigated the long-term effects of nonsurgical reduction of the septum on functional capacity and electrocardiographic and echocardiographic characteristics.
METHODS: Sixty-four consecutive patients with hypertrophic cardiomyopathy and a mean (+/-SD) age of 48.5+/-17.2 years underwent nonsurgical reduction of the septum by injection of ethanol into the septal perforator branch of the left anterior descending coronary artery. These patients were assessed by exercise testing, electrocardiography, and resting and dobutamine (stress-induced) echocardiography after a mean period of 3.0+/-1.3 years.
RESULTS: At follow-up, patients had significant improvements in New York Heart Association class, peak oxygen consumption (from 18.4+/-5.8 to 30.0+/-4.4 ml per kilogram of body weight per minute, P<0.001), and left ventricular outflow tract gradients (resting gradient, from 64+/-36 to 16+/-15 mm Hg; P<0.001; stress-induced gradient, from 132+/-34 to 45+/-19 mm Hg; P<0.001). Procedure-related complications included right bundle-branch block in all patients, complete heart block in 31 patients (48 percent), and significant increases in QRS and corrected QT intervals. Seventeen patients (27 percent) required permanent pacing. R-wave amplitude was significantly decreased (from 32+/-8 to 17+/-7 mV, P<0.001). The dimensions of the left ventricular cavity increased, and the interventricular septal thickness was reduced.
CONCLUSIONS: Nonsurgical septal reduction leads to sustained improvements in both subjective and objective measures of exercise capacity in association with a persistent reduction in resting and stress-induced left ventricular outflow tract gradients. It is also associated with a high incidence of procedure-related complete heart block, however, often requiring permanent pacing. Copyright 2002 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397190     DOI: 10.1056/NEJMoa012710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  7 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Symptomatic hypertrophic obstructive cardiomyopathy: semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient.

Authors:  Sanjay Kumar Dhar; Vatchsala Varadharajan; Abdallah Al-Mohammad; Julie Sandoval; Ever D Grech
Journal:  BMJ Case Rep       Date:  2009-03-31

Review 3.  What is new in pediatric cardiology.

Authors:  Monesha L Gupta; M Regina Lantin-Hermoso; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2003-01       Impact factor: 1.967

4.  Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery.

Authors:  Danita M Yoerger; Catherine A Best; Brendan M McQuillan; Gregory E Supple; J Luis Guererro; Joanne E Cluette-Brown; Ali Hasaba; Michael H Picard; James R Stone; Michael Laposata
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Doppler evaluation of the descending aorta in patients with hypertrophic cardiomyopathy: potential for assessing the functional significance of outflow tract gradients and for optimizing pacemaker function.

Authors:  Steven Mickelsen; Murali Bathina; Pamela Hsu; Joanna Holmes; Fred M Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2004-08       Impact factor: 1.900

6.  Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.

Authors:  Horst Kuhn; Thorsten Lawrenz; Frank Lieder; Christian Leuner; Claudia Strunk-Mueller; Ludger Obergassel; Markus Bartelsmeier; Christoph Stellbrink
Journal:  Clin Res Cardiol       Date:  2007-12-10       Impact factor: 5.460

7.  Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up.

Authors:  Paolo Stassano; Luigi Di Tommaso; Donato Triggiani; Antonio Contaldo; Cesare Gagliardi; Nicola Spampinato
Journal:  Tex Heart Inst J       Date:  2004
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.